Skip to main content

Bailey Gregory

In the past year, 1 open-market purchase filing worth $3.00M and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$3.00M
1 filing
Sold
–
0 filings
Net
+$3.00M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Bailey Gregory as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BHVN Biohaven Ltd.

Director7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 17, 2025 (view filing)Nov 134 daysBailey GregoryDirectorPPurchase+400.0K$7.50+$3.00M+24.7%2.02M after
Sep 25, 2024 (view filing)Sep 241 dayBailey GregoryDirectorPPurchase+5.00K$44.19+$220.9K+0.3%1.62M after
May 15, 2024 (view filing)May 132 daysBailey GregoryDirectorPPurchase+15.0K$34.19+$512.9K+0.9%1.62M after
Apr 25, 2024 (view filing)Apr 241 dayBailey GregoryDirectorPPurchase+25.5K$39.18+$999.2K+1.6%1.60M after
Apr 23, 2024 (view filing)Apr 221 dayBailey GregoryDirectorPPurchase+48.8K$41.00+$2.00M+3.2%1.57M after
Oct 6, 2023 (view filing)Oct 42 daysBailey GregoryDirectorPPurchase+17.8K$22.57+$402.1K+1.2%1.53M after
Oct 26, 2022 (view filing)Oct 251 dayBailey GregoryDirectorPPurchase+200.0K$10.50+$2.10M+15.3%1.51M after

SER Serina Therapeutics, Inc.

Director11 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 19, 2024 (view filing)Dec 172 daysBailey GregoryDirectorPPurchase+3.87K$4.59+$17.7K+6.1%67.2K after
Sep 24, 2024 (view filing)Sep 204 daysBailey GregoryDirectorPPurchase+1.14K$6.03+$6.86K+1.8%63.4K after
Sep 20, 2024 (view filing)Sep 18-192 daysBailey GregoryDirectorPPurchase+14.4K$6.13+$88.2K+30.1%62.2K after2 lots
Aug 22, 2024 (view filing)Aug 202 daysBailey GregoryDirectorPPurchase+1.78K$8.25+$14.7K+3.9%47.6K after
Aug 20, 2024 (view filing)Aug 15-195 daysLateBailey GregoryDirectorPPurchase+19.2K$7.30+$140.1K+72.2%45.8K after3 lots
Aug 16, 2024 (view filing)Aug 142 daysBailey GregoryDirectorPPurchase+6.40K$7.07+$45.2K+31.7%26.6K after
May 31, 2024 (view filing)May 29-302 daysBailey GregoryDirectorPPurchase+6.38K$9.50+$60.6K+46.1%20.2K after2 lots
May 29, 2024 (view filing)May 281 dayBailey GregoryDirectorPPurchase+9.02K$9.50+$85.7K+187.5%13.8K after
May 24, 2024 (view filing)May 21-233 daysLateBailey GregoryDirectorPPurchase+3.29K$9.50+$31.2K+216.0%4.81K after2 lots
May 23, 2024 (view filing)May 212 daysBailey GregoryDirectorPPurchase+1.42K$9.50+$13.5K+1,422.0%1.52K after

See all 11 trades at SER

Biohaven Pharmaceutical Holding Co Ltd.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 22, 2022 (view filing)Aug 193 daysBailey GregoryDirectorPPurchase+38.0K$148.04+$5.63M+1.5%2.58M after